Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Moser

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical Epigenetics|August 17, 2017
LSD1 dual function in mediating epigenetic corruption of the vitamin D signaling in prostate cancerSebastiano Battaglia, Ellen Karasik, Bryan Gillard, et al.
Cancer Research|December 21, 2006
DNA methylation pathway alterations in an autochthonous murine model of prostate cancerShannon R Morey, Dominic J Smiraglia, Smitha R James, et al.
Plos One|March 4, 2014
Early growth inhibition is followed by increased metastatic disease with vitamin D (calcitriol) treatment in the TRAMP model of prostate cancerAdebusola Alagbala Ajibade, Jason S Kirk, Ellen Karasik, et al.
Cancer Research|June 4, 2008
Phenotype-specific CpG island methylation events in a murine model of prostate cancerMarta Camoriano, Shannon R Morey Kinney, Michael T Moser, et al.
BJU International|January 18, 2007
Early effects of pharmacological androgen deprivation in human prostate cancerMaria Mercader, Shomik Sengupta, Barbara K Bodner, et al.
Frontiers in Oncology|February 23, 2023
Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancerShruti D Shah, Bryan M Gillard, Michelle M Wrobel, et al.
Oncotarget|April 29, 2020
Superior cancer preventive efficacy of low versus high dose of mTOR inhibitor in a mouse model of prostate cancerMarina P Antoch, Michelle Wrobel, Bryan Gillard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2004
Augmentation of T cell levels and responses induced by androgen deprivationAnja C Roden, Michael T Moser, Samuel D Tri, et al.
American Journal of Clinical and Experimental Urology|January 7, 2022
Patient derived models of bladder cancer enrich the signal of the tumor cell transcriptome facilitating the analysis of the tumor cell compartmentMichalis Mastri, Swathi Ramakrishnan, Shruti D Shah, et al.
Cancer Research|November 15, 2012
Definition of molecular determinants of prostate cancer cell bone extravasationSteven R Barthel, Danielle L Hays, Erika M Yazawa, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Epigenetics|August 17, 2017
LSD1 dual function in mediating epigenetic corruption of the vitamin D signaling in prostate cancerSebastiano Battaglia, Ellen Karasik, Bryan Gillard, et al.
Cancer Research|December 21, 2006
DNA methylation pathway alterations in an autochthonous murine model of prostate cancerShannon R Morey, Dominic J Smiraglia, Smitha R James, et al.
Plos One|March 4, 2014
Early growth inhibition is followed by increased metastatic disease with vitamin D (calcitriol) treatment in the TRAMP model of prostate cancerAdebusola Alagbala Ajibade, Jason S Kirk, Ellen Karasik, et al.
Cancer Research|June 4, 2008
Phenotype-specific CpG island methylation events in a murine model of prostate cancerMarta Camoriano, Shannon R Morey Kinney, Michael T Moser, et al.
BJU International|January 18, 2007
Early effects of pharmacological androgen deprivation in human prostate cancerMaria Mercader, Shomik Sengupta, Barbara K Bodner, et al.
Frontiers in Oncology|February 23, 2023
Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancerShruti D Shah, Bryan M Gillard, Michelle M Wrobel, et al.
Oncotarget|April 29, 2020
Superior cancer preventive efficacy of low versus high dose of mTOR inhibitor in a mouse model of prostate cancerMarina P Antoch, Michelle Wrobel, Bryan Gillard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2004
Augmentation of T cell levels and responses induced by androgen deprivationAnja C Roden, Michael T Moser, Samuel D Tri, et al.
American Journal of Clinical and Experimental Urology|January 7, 2022
Patient derived models of bladder cancer enrich the signal of the tumor cell transcriptome facilitating the analysis of the tumor cell compartmentMichalis Mastri, Swathi Ramakrishnan, Shruti D Shah, et al.
Cancer Research|November 15, 2012
Definition of molecular determinants of prostate cancer cell bone extravasationSteven R Barthel, Danielle L Hays, Erika M Yazawa, et al.
Pageof 3